BlackRock's position in Lilly(Eli) is currently worth $74B. That's 1.13% of their equity portfolio (13th largest holding). The investor owns 7.05% of the outstanding Lilly(Eli) stock. The first Lilly(Eli) trade was made in Q4 2020. Since then BlackRock bought shares ten more times and sold shares on seven occasions. The stake costed the investor $13.8B, netting the investor a gain of 435% so far.